dr. bendell on the next steps following progression on immunotherapy in msi-h crc
Published 6 years ago • 179 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:46
dr. bendell on the treatment of microsatellite stable patients with crc
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
0:54
dr. bendell discusses pembrolizumab in crc
-
9:02
pembrolizumab in msi-h crc tumors
-
1:34
dr. corcoran on immunotherapy for microsatellite stable/instable crc
-
1:28
dr. bekaii-saab on the response rate of pembrolizumab in msi-h crc
-
4:59
managing toxicities with immunotherapy in crc
-
8:34
relapsed/refractory mcrc: immunotherapy in msi-high tumors
-
1:09
dr. mccollum on immunotherapy in mss crc
-
1:37
dr. overman on next steps with immunotherapy in mcrc
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
1:05
dr. marshall on next steps following y-90 in liver-metastatic crc
-
6:11
immunotherapy in crc
-
5:49
immunotherapy and msi status in colorectal cancer
-
4:32
immunotherapy regimens in dmmr/msi-high metastatic crc
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
1:08
dr. ahn on left- versus right-sided tumors in crc
-
1:35
dr. chu on the role of pembrolizumab in dmmr/msi-h mcrc
-
2:00
dr. overman on nivolumab and ipilimumab in patients with msi-h crc